Skip to content

Total Assets at other companies

Pfizer logo
PfizerPFE
$207.62B-0.2%
Eikon Therapeutics, Inc.
 logo
Eikon Therapeutics, Inc. EIKN
$850.83M
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$183.97M-24.2%
Replimune Group logo
Replimune GroupREPL
$333.59M-44.7%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$1.03B-6.4%
Erasca, Inc. logo
Erasca, Inc.ERAS
$461.23M-2.1%

Other financials

Income statement

See full
Revenue-
Operating income-$15.6M+8.1%
Net income-$15.2M+4.8%
EPS (diluted)-$1.11+6.7%

Balance sheet

See full
Cash & equivalents$192.1M+98.7%
Total debt$409.0K-57.2%
Total equity$184.4M+103%

Cash flow

See full
Operating cash flow-$12.9M+7.6%
CapEx$5.0K-72.2%
Free cash flow-$12.9M+7.7%

Valuation

See full
Market cap$184.2M+71.8%
Enterprise value-$7.49M-130%

Returns & leverage

See full
Return on equity-42.7%
Debt / equity0.0×
Current ratio13.8×+2.6×

Where this comes from

Reported directly by OnKure Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s total assets?
OnKure Therapeutics, Inc. (OKUR) reported total assets of $198.69M in Q1 2026.
How has OnKure Therapeutics, Inc.'s total assets changed year-over-year?
OnKure Therapeutics, Inc.'s total assets increased by 98.9% year-over-year, from $99.88M to $198.69M.
What is the long-term trend for OnKure Therapeutics, Inc.'s total assets?
Over 5 years (2020 to 2025), OnKure Therapeutics, Inc.'s total assets has grown at a 2.4% compound annual growth rate (CAGR), from $55.22M to $62.12M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.